Previewing the 2nd Half of 2020…and Other Updates From The Week

Greetings from...wait for it...Ashland Oregon. Yes, it was so good, we came back for more. The weather here is great, the riding is outstanding...

TFF Pharmaceuticals Announces First Human Dosing With Tacrolimus Inhalation Powder and Topline Data for...

Tailwinds' Take: TFF's unique drug delivery platform is proving itself to be safer and more efficacious than pill or oral delivery. The Company has...

Summer is Coming

When you receive this newsletter, it will be June 21st, the official start of summer. Typically for stocks you have a summer doldrums, "sell...

TFF Pharmaceuticals Receives Orphan Drug Designation for Tacrolimus Inhalation Powder

Tailwinds' Take: the most important takeaway here is the execution of the team at an early stage company. TFFP is poised to disrupt pharma...

Three Disruptive Plays…And Other Thoughts From Last Week

The world of micro-cap is full of little stocks with big ideas. It seems like a large number of these companies have no sales,...

June Preview…Plus Much More!

May was another strong month for the market as the stimulus package and expectations for a strong re-opening of the economy kept the rebound...

Bada Bing Bada Boom

As if on cue, the market took a turn lower last week. This will be but a quick note on the market, as I'm...

TFF Pharmaceuticals Reports First Quarter 2020 Financial and Business Results

AUSTIN, Texas--(BUSINESS WIRE)--May 14, 2020--TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented...

The Eye Of The Storm…This Week In Tailwinds’ World

Well, I've been expecting it and it appears that it's here. The market put up one of its best months ever in April, but...

TFF Pharmaceuticals’ Inventor Dr. Robert O. Williams III Presents Session on Repurposing Niclosamide for...

Tailwinds' Take: this is potentially huge news. This quote, "Niclosamide has been shown to be considerably more potent when compared with other drugs such...

This Week in Stocks

While the markets may not have had the most volatile week of the year, nor come close, it was a very topsy-turvy five days...

Saturday Morning Ramblings…

Another great week in the market. The economy is in free-fall, unemployment is skyrocketing and stocks can't stop going up. How is this possible?...

TFF Pharmaceuticals Announces Cooperative Research and Development Agreement (CRADA) with the United States Army...

Tailwinds' Take: this quote from CEO Mattes says it all, “This CRADA, with the world’s preeminent biodefense research organization, is another validation of Thin...

This Week In MicroCap

It was certainly a great week for the market as a number of positive factors contributed to the continuation of what is a very...

IF Alpha?

My biggest concern last fall was, "what if Bernie gets into office?" This fear was driven partially by the fact that the market would...

TFF Pharmaceuticals Reports Fourth Quarter Results and Full Year 2019 Financial and Business Results

AUSTIN, Texas--(BUSINESS WIRE)--Mar. 26, 2020-- TFF Pharmaceuticals, Inc. (NASDAQ:TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin...

There’s Blood In The Streets…

Normally I love my Saturday mornings. This is when I write the weekly newsletter and it gives me a chance to review the prior...

TFF Pharmaceuticals Announces Phase 1 Clinical Trial Progress for Voriconazole Inhalation Powder to Treat...

Tailwinds' Take: Voriconazole is a generic liquid or tablet that is ingested for diseases like IPA, which start in the lungs. Having a direct...

It’s Definitely a Beer Market

Sometimes a typo can hit the sweet spot, right? When I got the text that we're entering a beer market...well, let's just say that...

TFF Pharmaceuticals Announces Engagement of J.S. Cole & Associates as Strategic Advisor for Partnering...

Tailwinds' Take: very interesting that they have engaged two firms for partnership efforts, first in China, now Japan. We continue to believe that this...
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.